{"id":"losartan-control","safety":{"commonSideEffects":[{"rate":"7-10","effect":"Dizziness"},{"rate":"3-5","effect":"Fatigue"},{"rate":"2-4","effect":"Hyperkalemia"},{"rate":"1-3","effect":"Cough"},{"rate":"1-2","effect":"Hypotension"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Losartan is an angiotensin II receptor blocker (ARB) that selectively antagonizes AT1 receptors on vascular smooth muscle and adrenal tissue. By blocking angiotensin II signaling, it causes vasodilation, reduces peripheral vascular resistance, and decreases aldosterone-mediated sodium and water retention, resulting in blood pressure reduction and improved renal protection.","oneSentence":"Losartan blocks angiotensin II type 1 (AT1) receptors, preventing vasoconstriction and aldosterone release to lower blood pressure.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:19:28.124Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Hypertension"},{"name":"Diabetic nephropathy in patients with type 2 diabetes"},{"name":"Heart failure with reduced ejection fraction"},{"name":"Post-myocardial infarction"}]},"trialDetails":[{"nctId":"NCT07449000","phase":"NA","title":"Losartan for Corneal Fibrosis","status":"RECRUITING","sponsor":"Universidad Autonoma de Nuevo Leon","startDate":"2026-02-12","conditions":"Corneal Scarring Fibrosis","enrollment":46},{"nctId":"NCT05619653","phase":"PHASE3","title":"Myocardial Protection in Patients With Post-acute Inflammatory Cardiac Involvement Due to COVID-19","status":"ACTIVE_NOT_RECRUITING","sponsor":"Valentina Puentmann","startDate":"2022-12-12","conditions":"COVID-19 Associated Cardiac Involvement, Remodeling, Left Ventricle, Remodeling, Vascular","enrollment":279},{"nctId":"NCT06796660","phase":"EARLY_PHASE1","title":"Exploring the Impact of Nephropathy Formula No. 1 on Chronic Kidney Disease Patients","status":"NOT_YET_RECRUITING","sponsor":"Liu Zhanghong","startDate":"2025-09-01","conditions":"Renal Insufficiency, Chronic","enrollment":70},{"nctId":"NCT05331144","phase":"PHASE2","title":"Impact of Intensive Treatment of SBP on Brain Perfusion, Amyloid, and Tau (IPAT Study)","status":"RECRUITING","sponsor":"Rong Zhang","startDate":"2022-10-25","conditions":"Cognitively Normal Older Adults, Hypertension, Subjective Cognitive Decline","enrollment":180},{"nctId":"NCT06150560","phase":"PHASE3","title":"A Study of Angiotensin-II Receptor Blocker on Cardiovascular Remodeling (VALUE Trial)","status":"RECRUITING","sponsor":"Mayo Clinic","startDate":"2024-04-01","conditions":"Coarctation of Aorta, High Blood Pressure","enrollment":120},{"nctId":"NCT06624904","phase":"EARLY_PHASE1","title":"Losartan and Social Processing","status":"RECRUITING","sponsor":"University of Oxford","startDate":"2024-08-19","conditions":"Social Cognition","enrollment":68},{"nctId":"NCT03354143","phase":"PHASE2","title":"Hypertension, Intracranial Pulsatility and Brain Amyloid-beta Accumulation in Older Adults (HIPAC Trial)","status":"COMPLETED","sponsor":"University of Texas Southwestern Medical Center","startDate":"2018-04-10","conditions":"Hypertension","enrollment":85},{"nctId":"NCT06636812","phase":"EARLY_PHASE1","title":"Losartan and Emotional Processing in Young People","status":"RECRUITING","sponsor":"University of Oxford","startDate":"2024-03-07","conditions":"Emotional Processing","enrollment":60},{"nctId":"NCT04158154","phase":"NA","title":"Transforming Hypertension Treatment in Nigeria Using a Type II Hybrid, Interrupted Time Series Design","status":"COMPLETED","sponsor":"Washington University School of Medicine","startDate":"2020-02-01","conditions":"Hypertension","enrollment":21922},{"nctId":"NCT06831864","phase":"PHASE1","title":"Heart Failure With Reduced Ejection Fraction Polypill Implementation Strategy in Sri Lanka","status":"COMPLETED","sponsor":"Washington University School of Medicine","startDate":"2025-02-15","conditions":"Heart Failure With Reduced Ejection Fraction","enrollment":40},{"nctId":"NCT06135493","phase":"PHASE2","title":"Prevention of Paclitaxel-induced Peripheral Neuropathy in Breast Cancer Patients","status":"COMPLETED","sponsor":"Future University in Egypt","startDate":"2023-12-12","conditions":"Peripheral Neuropathy Due to Chemotherapy","enrollment":84},{"nctId":"NCT05365893","phase":"EARLY_PHASE1","title":"PHL Treatment in Pancreatic Cancer","status":"RECRUITING","sponsor":"Fox Chase Cancer Center","startDate":"2021-10-20","conditions":"Pancreatic Ductal Adenocarcinoma","enrollment":20},{"nctId":"NCT02560805","phase":"PHASE2","title":"Role of Sympathetic Overactivity and Angiotensin II in PTSD and CV","status":"SUSPENDED","sponsor":"Emory University","startDate":"2015-10","conditions":"Stress Disorders, Post-Traumatic","enrollment":134},{"nctId":"NCT05576155","phase":"EARLY_PHASE1","title":"Sex Differences in the Dilatory Response of Compound 21","status":"COMPLETED","sponsor":"Anna Stanhewicz, PhD","startDate":"2022-10-03","conditions":"Sex Differences","enrollment":26},{"nctId":"NCT06628154","phase":"EARLY_PHASE1","title":"Losartan and Emotional Learning","status":"RECRUITING","sponsor":"University of Oxford","startDate":"2024-08-14","conditions":"Emotional Processing","enrollment":60},{"nctId":"NCT06333522","phase":"PHASE4","title":"Losartan Use to Mitigate Arthrofibrosis Following Total Joint Arthroplasty","status":"WITHDRAWN","sponsor":"NYU Langone Health","startDate":"2024-07-01","conditions":"Arthrofibrosis of Knee","enrollment":""},{"nctId":"NCT00140907","phase":"PHASE4","title":"ALLOGRAFT, A Study to Evaluate the Renal Protective Effects of Losartan (0954-222)(COMPLETED)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2000-03-14","conditions":"High Blood Pressure","enrollment":367},{"nctId":"NCT06539806","phase":"NA","title":"Clinical Study Evaluating the Effect of Losartan","status":"RECRUITING","sponsor":"Tanta University","startDate":"2024-07-20","conditions":"Pancreatic Cancer","enrollment":90},{"nctId":"NCT04335123","phase":"PHASE1","title":"Study of Open Label Losartan in COVID-19","status":"COMPLETED","sponsor":"University of Kansas Medical Center","startDate":"2020-04-04","conditions":"COVID-19","enrollment":34},{"nctId":"NCT02735707","phase":"PHASE3","title":"Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia","status":"RECRUITING","sponsor":"UMC Utrecht","startDate":"2016-04-11","conditions":"Community-acquired Pneumonia, Influenza, COVID-19","enrollment":20000},{"nctId":"NCT06366386","phase":"","title":"Integrating Hypertension Management in DSD for HIV","status":"NOT_YET_RECRUITING","sponsor":"Infectious Diseases Research Collaboration, Uganda","startDate":"2024-06-15","conditions":"Hypertension, HIV","enrollment":1100},{"nctId":"NCT06431477","phase":"PHASE4","title":"Efficacy and Safety of Telmisartan Compared With Losartan","status":"RECRUITING","sponsor":"Chong Kun Dang Pharmaceutical","startDate":"2023-04-19","conditions":"Diabetic Nephropathies, Hypertension","enrollment":98},{"nctId":"NCT00568178","phase":"PHASE3","title":"An Extension Study Designed to Assess Effects of Losartan on Proteinuria in Pediatric Populations (MK-0954-326 AM1,EXT1(AM2))","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2007-06-01","conditions":"Proteinuria","enrollment":306},{"nctId":"NCT00496834","phase":"PHASE4","title":"LAAS (Losartan Anti-Atherosclerosis Study)(0954-330)(COMPLETED)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2008-02-01","conditions":"Hypertension","enrollment":201},{"nctId":"NCT01307046","phase":"PHASE3","title":"MK-0954A in Japanese Patients With Essential Hypertension Not Adequately Controlled With Losartan (MK-0954A-352)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2011-03-29","conditions":"Hypertension","enrollment":336},{"nctId":"NCT01307033","phase":"PHASE3","title":"A Long-term Study of the Safety of MK-0954A in Patients With Essential Hypertension (MK-0954A-351)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2011-03-29","conditions":"Hypertension","enrollment":278},{"nctId":"NCT00546754","phase":"PHASE3","title":"BP-EASE -Effectiveness of Losartan 50 mg/Hydrochlorothiazide (HCTZ) 12.5 mg Versus Valsartan 80 mg/HCTZ 12.5 mg Titrated as Needed in Patients With Essential Hypertension Not Controlled on Monotherapy (0954A-333)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2007-05-01","conditions":"Hypertension","enrollment":808},{"nctId":"NCT02263729","phase":"PHASE1, PHASE2","title":"Phase 1/2 Prospective Double-Blind Placebo-Controlled Randomized Clinical Trial of Losartan to Treat Grade II & III Hamstring Strains","status":"TERMINATED","sponsor":"James J. Irrgang","startDate":"2016-08-10","conditions":"Hamstring Injury","enrollment":8},{"nctId":"NCT04815902","phase":"PHASE1, PHASE2","title":"Use of Senolytic and Anti-Fibrotic Agents to Improve the Beneficial Effect of Bone Marrow Stem Cells for Osteoarthritis","status":"ACTIVE_NOT_RECRUITING","sponsor":"Steadman Philippon Research Institute","startDate":"2021-05-18","conditions":"Osteoarthritis, Knee","enrollment":100},{"nctId":"NCT05025956","phase":"PHASE1, PHASE2","title":"Senolytic Agent Improve the Benefit of Platelet-Rich Plasma and Losartan","status":"ACTIVE_NOT_RECRUITING","sponsor":"Steadman Philippon Research Institute","startDate":"2021-10-24","conditions":"Femoroacetabular Impingement","enrollment":68},{"nctId":"NCT06329050","phase":"NA","title":"The Effects of Losartan on Attention Control: An Eye-tracking Study","status":"RECRUITING","sponsor":"University of Electronic Science and Technology of China","startDate":"2024-03-05","conditions":"Healthy","enrollment":80},{"nctId":"NCT06108063","phase":"PHASE1, PHASE2","title":"Mitigation of Arthrofibrosis After Total Knee Arthroplasty Using Losartan","status":"RECRUITING","sponsor":"Steadman Philippon Research Institute","startDate":"2024-03-06","conditions":"Knee Arthroplasty, Total","enrollment":120},{"nctId":"NCT05157464","phase":"PHASE4","title":"Losartan Use to Mitigate Arthrofibrosis Following Total Join Arthroplasty","status":"WITHDRAWN","sponsor":"NYU Langone Health","startDate":"2023-09-01","conditions":"Arthrofibrosis","enrollment":""},{"nctId":"NCT04212650","phase":"PHASE1, PHASE2","title":"Losartan to Improve Hip Microfracture","status":"TERMINATED","sponsor":"Steadman Philippon Research Institute","startDate":"2020-08-07","conditions":"Hip Osteoarthritis, Hip Impingement Syndrome, Cartilage Damage","enrollment":1},{"nctId":"NCT05199129","phase":"PHASE3","title":"Clinical Efficacy and Safety Evaluation of HCP1904-3 in Essential Hypertension Patients","status":"COMPLETED","sponsor":"Hanmi Pharmaceutical Company Limited","startDate":"2021-11-17","conditions":"Hypertension","enrollment":166},{"nctId":"NCT04830449","phase":"PHASE3","title":"Clinical Efficacy and Safety Evaluation of HCP1904-2 in Essential Hypertension Patients","status":"COMPLETED","sponsor":"Hanmi Pharmaceutical Company Limited","startDate":"2020-10-29","conditions":"Hypertension","enrollment":122},{"nctId":"NCT04820907","phase":"PHASE3","title":"Clinical Efficacy and Safety Evaluation of HCP1904-1 in Essential Hypertension Patients","status":"COMPLETED","sponsor":"Hanmi Pharmaceutical Company Limited","startDate":"2020-10-27","conditions":"Hypertension","enrollment":123},{"nctId":"NCT05271448","phase":"NA","title":"Continuing or Discontinuing ACE/ARBs in Patients With Chronic Kidney Disease Undergoing Coronary Angiography","status":"UNKNOWN","sponsor":"An-Najah National University","startDate":"2021-06-01","conditions":"Contrast-induced Nephropathy, Chronic Kidney Diseases, Ischemic Heart Disease","enrollment":600},{"nctId":"NCT05843162","phase":"PHASE4","title":"A Clinical Trial to Evaluate the Blood Pressure Control of Telmisartan or Losartan in Essential Hypertensive Patients With Metabolic Syndrome","status":"UNKNOWN","sponsor":"Chong Kun Dang Pharmaceutical","startDate":"2023-06-01","conditions":"Essential Hypertension, Metabolic Syndrome","enrollment":116},{"nctId":"NCT01845688","phase":"NA","title":"Clinical Study of QingReMoShen Granule to Treat Idiopathic Membranous Nephropathy","status":"COMPLETED","sponsor":"wanglin","startDate":"2011-11","conditions":"Idiopathic Membranous Nephropathy","enrollment":72},{"nctId":"NCT02817360","phase":"PHASE4","title":"NT-proBNP Selected Prevention of Cardiac Events in Diabetic Patients","status":"RECRUITING","sponsor":"Martin Huelsmann","startDate":"2016-02","conditions":"Heart Diseases, Diabetes Mellitus, Type 2","enrollment":2400},{"nctId":"NCT05064904","phase":"NA","title":"Multidiscipline Care for Acute Kidney Disease (AKD)","status":"UNKNOWN","sponsor":"National Taiwan University Hospital","startDate":"2019-02-15","conditions":"Acute Kidney Injury","enrollment":300},{"nctId":"NCT04606563","phase":"PHASE3","title":"Host Response Mediators in Coronavirus (COVID-19) Infection - Is There a Protective Effect of Losartan and Other ARBs on Outcomes of Coronavirus Infection?","status":"TERMINATED","sponsor":"University of British Columbia","startDate":"2020-10-09","conditions":"Covid19, SARS-CoV Infection","enrollment":341},{"nctId":"NCT02188121","phase":"PHASE4","title":"Fixed Dose Intervention Trial of New England Enhancing Survival in SMI Patients","status":"COMPLETED","sponsor":"Mclean Hospital","startDate":"2015-02","conditions":"Serious Mental Illness, Schizophrenia, Schizoaffective Disorder","enrollment":227},{"nctId":"NCT05631782","phase":"EARLY_PHASE1","title":"Effects of Shenkang Decoction on Creatinine and Blood Urea Nitrogen in Chronic Renal Failure Hemodialysis Patients","status":"COMPLETED","sponsor":"The First People's Hospital of Zunyi","startDate":"2020-11-10","conditions":"Chronic Renal Failure, Hemodialysis","enrollment":160},{"nctId":"NCT03666351","phase":"PHASE4","title":"Study to Evaluate the Effect on Improvement of LVH by the Control of BP in Hypertension Patients With AV Disease","status":"COMPLETED","sponsor":"Hanmi Pharmaceutical Company Limited","startDate":"2018-10-18","conditions":"Aortic Stenosis, Aortic Regurgitation, Hypertension","enrollment":128},{"nctId":"NCT03461003","phase":"PHASE4","title":"N-of-1 Trials In Children With Hypertension","status":"COMPLETED","sponsor":"The University of Texas Health Science Center, Houston","startDate":"2018-04-02","conditions":"Pediatric Hypertension","enrollment":49},{"nctId":"NCT04312009","phase":"PHASE2","title":"Losartan for Patients With COVID-19 Requiring Hospitalization","status":"COMPLETED","sponsor":"University of Minnesota","startDate":"2020-04-13","conditions":"Corona Virus Infection, Acute Respiratory Distress Syndrome, SARS-CoV Infection","enrollment":205},{"nctId":"NCT02620306","phase":"PHASE3","title":"A Randomized, Double-blind, Active Control, Parallel Group, Titration, Multicenter Study to Evaluate the Efficacy and Safety of Fimasartan","status":"COMPLETED","sponsor":"Boryung Pharmaceutical Co., Ltd","startDate":"2016-02-11","conditions":"Chronic Kidney Disease","enrollment":351},{"nctId":"NCT02246257","phase":"NA","title":"Early Rheumatoid Arthritis COR Intervention","status":"UNKNOWN","sponsor":"MD, PhD, Annemarie Lyng Svensson","startDate":"2014-09","conditions":"Rheumatoid Arthritis, Cardiovascular Diseases","enrollment":300},{"nctId":"NCT04311177","phase":"PHASE2","title":"Losartan for Patients With COVID-19 Not Requiring Hospitalization","status":"COMPLETED","sponsor":"University of Minnesota","startDate":"2020-04-09","conditions":"Corona Virus Infection, Acute Respiratory Distress Syndrome, SARS-CoV Infection","enrollment":117},{"nctId":"NCT05349825","phase":"","title":"Investigation of MDR1 Gene Polymorphism and Losartan Plasma Concentration in Patients Undergoing Hypertensive Episodes While Under Losartan Treatment","status":"COMPLETED","sponsor":"Pamukkale University","startDate":"2017-10-23","conditions":"Hypertension","enrollment":100},{"nctId":"NCT04394117","phase":"PHASE4","title":"Controlled evaLuation of Angiotensin Receptor Blockers for COVID-19 respIraTorY Disease","status":"COMPLETED","sponsor":"The George Institute","startDate":"2020-06-19","conditions":"Coronavirus Disease 2019, COVID-19","enrollment":787},{"nctId":"NCT05243446","phase":"","title":"Cardiorenal Effecs of Losartan in Kidney Transplant Recipients","status":"UNKNOWN","sponsor":"Medical University of Gdansk","startDate":"2015-09","conditions":"Renal Transplant Failure, Cardiovascular Complication","enrollment":740},{"nctId":"NCT00092209","phase":"PHASE3","title":"Antihypertensive Efficacy and Safety of Approved Drugs in Japanese Patients With Essential Hypertension (Banyu Study)(0954A-302)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2002-04","conditions":"Hypertension","enrollment":840},{"nctId":"NCT00308347","phase":"PHASE3","title":"A Research Study to Evaluate the Renal (Kidney) Protective Effects of Losartan in Patients With Non-insulin Dependent Diabetes (0954-147)(COMPLETED)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"1996-05","conditions":"Type 2 Diabetes, Nephropathy","enrollment":1513},{"nctId":"NCT02913664","phase":"PHASE2, PHASE3","title":"Risk Reduction for Alzheimer's Disease","status":"COMPLETED","sponsor":"University of Texas Southwestern Medical Center","startDate":"2017-02-02","conditions":"Cognitively Normal Older Adults, Hypertension, Subjective Cognitive Decline","enrollment":513},{"nctId":"NCT05232370","phase":"PHASE2","title":"The Effect of Enalapril, Losartan or Not Antihypertensive on the Oxidative Status in Renal Transplant Recipients","status":"COMPLETED","sponsor":"Unidad de Investigacion Medica en Enfermedades Renales","startDate":"2022-01-01","conditions":"Oxidative Stress","enrollment":39},{"nctId":"NCT00943852","phase":"PHASE1","title":"The Effect of Losartan and Losartan Plus Isosorbide Mononitrate on Central Blood Pressure Measurements (0954-317)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2006-08","conditions":"Hypertension","enrollment":13},{"nctId":"NCT05132712","phase":"EARLY_PHASE1","title":"Effects of Angiotensin Converting Enzyme Inhibitors on Patency of Arterio-Venous Fistulas: A Randomized Controlled Trial","status":"UNKNOWN","sponsor":"Armed Forces Post Graduate Medical Institute (AFPGMI), Rawalpindi","startDate":"2021-10-01","conditions":"Vascular Access Complication","enrollment":100},{"nctId":"NCT03467217","phase":"PHASE2","title":"Losartan for the Treatment of Pediatric NAFLD","status":"TERMINATED","sponsor":"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","startDate":"2018-10-02","conditions":"NAFLD - Nonalcoholic Fatty Liver Disease","enrollment":83},{"nctId":"NCT04238702","phase":"PHASE4","title":"Renohemodynamic Effects of Combined empagliflOzin and LosARtan","status":"COMPLETED","sponsor":"Amsterdam UMC, location VUmc","startDate":"2020-11-04","conditions":"Diabetes Mellitus, Type 2, Diabetic Kidney Disease","enrollment":24},{"nctId":"NCT00720577","phase":"EARLY_PHASE1","title":"Study to Evaluate the Effect of Simvastatin, Losartan and Pioglitazone on Patients With Peripheral Arterial Disease.","status":"COMPLETED","sponsor":"Medtronic Endovascular","startDate":"2005-12","conditions":"Peripheral Arterial Disease","enrollment":164},{"nctId":"NCT02709018","phase":"NA","title":"A Controlled Trial of Losartan in Posttraumatic Stress Disorder","status":"COMPLETED","sponsor":"University of California, San Diego","startDate":"2016-07-16","conditions":"Posttraumatic Stress Disorder","enrollment":149},{"nctId":"NCT04428268","phase":"PHASE2","title":"Chloroquine + Losartan Compared to Chloroquine Alone for the Treatment of COVID-19 Pneumonia","status":"WITHDRAWN","sponsor":"Hospital Universitario Dr. Jose E. Gonzalez","startDate":"2020-03-10","conditions":"COVID-19 Pneumonia","enrollment":""},{"nctId":"NCT03335904","phase":"PHASE4","title":"AT1R Blockade and Periodic Breathing During Sleep in Hypoxia","status":"COMPLETED","sponsor":"University of British Columbia","startDate":"2018-01-01","conditions":"Sleep Disordered Breathing, Hypoxia, Respiration; Sleep Disorder","enrollment":14},{"nctId":"NCT04330300","phase":"PHASE4","title":"Coronavirus (COVID-19) ACEi/ARB Investigation","status":"SUSPENDED","sponsor":"National University of Ireland, Galway, Ireland","startDate":"2020-04-30","conditions":"Hypertension, COVID-19","enrollment":2414},{"nctId":"NCT04278495","phase":"NA","title":"The Effect of Losartan on the Recoverability of Renal Function in Anuric and Oliguric Patients With Unilateral Obstructed Kidney","status":"COMPLETED","sponsor":"Mansoura University","startDate":"2014-09-01","conditions":"Losartan Adverse Reaction, Uropathy, Uropathy Obstructive","enrollment":96},{"nctId":"NCT03953950","phase":"PHASE4","title":"Effect of Add-on Spironolactone to Losartan Versus Losartan Alone on Peritoneal Membrane Among Peritoneal Dialysis Patients","status":"UNKNOWN","sponsor":"Chiang Mai University","startDate":"2019-10","conditions":"End Stage Renal Disease, Peritoneal Dialysis","enrollment":84},{"nctId":"NCT04061824","phase":"PHASE4","title":"Clinical Study to Evaluate Adherence Improvement Fixed-dose Combination of Olostar Tab. in Patients With Hypertension and Dyslipidemia","status":"COMPLETED","sponsor":"Yonsei University","startDate":"2016-05-24","conditions":"Hypertension, Dyslipidemias","enrollment":150},{"nctId":"NCT01302691","phase":"PHASE3","title":"MK-0954E Study in Participants With Hypertension (MK-0954E-357)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2011-01-01","conditions":"Hypertension","enrollment":327},{"nctId":"NCT01033318","phase":"PHASE1","title":"A Study of the Pharmacokinetics and Pharmacodynamics of MK1809 (1809-001)(COMPLETED)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2007-09-11","conditions":"Hypertension","enrollment":30},{"nctId":"NCT00675987","phase":"PHASE4","title":"A Randomized Clinical Trial To Study Losartan On Endothelial Dysfunction and Insulin Resistance In Obese Patients","status":"COMPLETED","sponsor":"Brigham and Women's Hospital","startDate":"2007-05","conditions":"Obesity, Hypertension, Hyperglycemia","enrollment":53},{"nctId":"NCT03578042","phase":"PHASE4","title":"Fixed-Free HTN Trial","status":"UNKNOWN","sponsor":"Hotel Dieu de France Hospital","startDate":"2017-04-01","conditions":"Hypertension","enrollment":100},{"nctId":"NCT03526042","phase":"NA","title":"Angiotensin-II Receptor Antibodies Blockade With Losartan in Patients With Lupus Nephritis","status":"UNKNOWN","sponsor":"Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran","startDate":"2017-09-10","conditions":"Atherosclerosis, Lupus Nephritis","enrollment":40},{"nctId":"NCT00922480","phase":"PHASE3","title":"Clinical Study to Evaluate the Antihypertensive Efficacy and Safety of Fimasartan in Hypertension Patients","status":"COMPLETED","sponsor":"Boryung Pharmaceutical Co., Ltd","startDate":"2008-12","conditions":"Hypertension","enrollment":506},{"nctId":"NCT03357653","phase":"PHASE3","title":"Beginning of Effective and Safe Treatment in Immunoglobulin A-1 Nephropathy-1","status":"UNKNOWN","sponsor":"Ewha Womans University","startDate":"2018-01-30","conditions":"Glomerulonephritis, Immunoglobulin A (IgA)","enrollment":174},{"nctId":"NCT03147092","phase":"EARLY_PHASE1","title":"Matão Controlling Hypertension (MatCH Study): Rationale and Design","status":"UNKNOWN","sponsor":"Centro Neurológico de Pesquisa e Reabiitação, Brazil","startDate":"2018-02-01","conditions":"Hypertension, Blood Pressure","enrollment":15000},{"nctId":"NCT00354991","phase":"PHASE3","title":"Hyzaar Asia HEAALTH (0954A-950)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2006-06-01","conditions":"Hypertension","enrollment":437},{"nctId":"NCT02294539","phase":"PHASE4","title":"Comparison of Effects Between Amlodipine and Hydrochlorothiazide in Combination With Losartan on 24-hr Central Blood Pressure in Hypertensive Patients","status":"COMPLETED","sponsor":"Chong-Jin Kim","startDate":"2014-08","conditions":"Hypertension","enrollment":231},{"nctId":"NCT02521246","phase":"PHASE3","title":"Efficacy and Safety of Candesartan Associated With Chlorthalidone Versus Losartan Associated With Hydrochlorothiazide (Hyzaar®) in Essential Hypertension Control","status":"WITHDRAWN","sponsor":"EMS","startDate":"2016-11","conditions":"Essential Arterial Hypertension","enrollment":""},{"nctId":"NCT02521233","phase":"PHASE3","title":"Efficacy and Safety of Candesartan Associated With Chlorthalidone in Essential Arterial Hypertension Control","status":"WITHDRAWN","sponsor":"EMS","startDate":"2016-11","conditions":"Essential Arterial Hypertension","enrollment":""},{"nctId":"NCT00344110","phase":"PHASE3","title":"Study Comparing SPP100 (Aliskiren) 150mg to Placebo and to Losartan 50mg in Patients With Mild to Moderate Essential Hypertension","status":"COMPLETED","sponsor":"Novartis","startDate":"2006-06","conditions":"Hypertension","enrollment":768},{"nctId":"NCT02916602","phase":"PHASE3","title":"A Study to Evaluate Efficacy and Safety of HCP1401 for Stage 2 Hypertension Patients Not Controlled by HCP0605","status":"COMPLETED","sponsor":"Hanmi Pharmaceutical Company Limited","startDate":"2015-04","conditions":"Hypertension","enrollment":340},{"nctId":"NCT00940667","phase":"PHASE3","title":"Efficacy/Safety of Amlodipine Plus Losartan Versus Amlodipine in Patients With Essential Hypertension","status":"COMPLETED","sponsor":"Hanmi Pharmaceutical Company Limited","startDate":"2008-05","conditions":"Hypertension","enrollment":185},{"nctId":"NCT02900729","phase":"PHASE3","title":"Randomized Controlled Trial of Renal Denervation for Resistant Hypertension","status":"UNKNOWN","sponsor":"Shanghai WiseGain Medical Devices Co., Ltd.","startDate":"2016-10","conditions":"Hypertension","enrollment":254},{"nctId":"NCT02231125","phase":"PHASE4","title":"Efficacy and Safety of Abelmoschus Manihot for IgA Nephropathy","status":"UNKNOWN","sponsor":"Chen Xiangmei","startDate":"2014-09","conditions":"IgA Nephropathy","enrollment":1600},{"nctId":"NCT01603940","phase":"PHASE4","title":"Comparison Between Losartan and Benazepril in Diabetic Hypertensive Patients Not Controlled by Amlodipine","status":"COMPLETED","sponsor":"Hospital Universitario Pedro Ernesto","startDate":"2012-05","conditions":"Hypertension, Diabetes Mellitus","enrollment":30},{"nctId":"NCT00856960","phase":"PHASE1","title":"The Effect of Hypertension Medications on Renal Blood Flow Measurements in Healthy Males (MK-0000-127)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2010-01","conditions":"Hypertension","enrollment":12},{"nctId":"NCT01230216","phase":"PHASE4","title":"Effect of Intensive Blood Pressure Control on Progression of Coronary Atherosclerosis: Randomized Evaluation by Intravascular Ultrasound","status":"TERMINATED","sponsor":"Takeshi Morimoto","startDate":"2010-12","conditions":"Coronary Artery Disease, Hypertension","enrollment":8},{"nctId":"NCT01051219","phase":"PHASE3","title":"Anti-Fibrotic Effects of Losartan In Nash Evaluation Study","status":"COMPLETED","sponsor":"Newcastle-upon-Tyne Hospitals NHS Trust","startDate":"2011-05","conditions":"Nonalcoholic Steatohepatitis","enrollment":45},{"nctId":"NCT00886600","phase":"PHASE3","title":"A Study to Investigate the Magnitude and Duration of Response of MK0954 Compared to Placebo in Patients With Hypertension (0954-021)(COMPLETED)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"1991-05","conditions":"Hypertension","enrollment":122},{"nctId":"NCT00882440","phase":"PHASE3","title":"A Study to Investigate the Efficacy and Safety of Different Doses of Losartan Potassium (MK0954-011)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"1990-12","conditions":"Hypertension","enrollment":576},{"nctId":"NCT01150201","phase":"PHASE4","title":"Aliskiren Combined With Losartan in Proteinuric, Non-diabetic Chronic Kidney Disease","status":"COMPLETED","sponsor":"The University of Hong Kong","startDate":"2009-07","conditions":"Kidney Disease","enrollment":80},{"nctId":"NCT02063100","phase":"PHASE4","title":"Efficacy and Safety of Shenyankangfu Tablets for Primary Glomerulonephritis","status":"UNKNOWN","sponsor":"Chinese PLA General Hospital","startDate":"2014-02","conditions":"Glomerulonephritis, Proteinuria","enrollment":720},{"nctId":"NCT01675362","phase":"PHASE4","title":"Are There Protective Effects of Antioxidants, Calcium Channel Blocker and Angiotensin Receptor Blocker Against Extracorporeal Shockwaves Lithotripsy Induced Renal Injury?","status":"COMPLETED","sponsor":"Mansoura University","startDate":"2012-08","conditions":"Kidney Calculi","enrollment":160},{"nctId":"NCT02190318","phase":"NA","title":"Residual Renal Function Preservation in Peritoneal Dialysis Patients","status":"UNKNOWN","sponsor":"Second Xiangya Hospital of Central South University","startDate":"2013-11","conditions":"Chronic Renal Disease","enrollment":96},{"nctId":"NCT00446862","phase":"","title":"The Fabrazyme® and Arbs and ACE Inhibitor Treatment (FAACET) Study","status":"COMPLETED","sponsor":"University of Alabama at Birmingham","startDate":"2007-03","conditions":"Fabry Disease, Proteinuria","enrollment":36},{"nctId":"NCT01011062","phase":"NA","title":"Effect of Angiotensin Receptor Blockade on Insulin Resistance and Adipose Tissue Cytokines in Type 2 Diabetes","status":"COMPLETED","sponsor":"Institute for Clinical and Experimental Medicine","startDate":"2004-01","conditions":"Insulin Resistance, Type 2 Diabetes","enrollment":23},{"nctId":"NCT01398423","phase":"PHASE2","title":"INV-144 Versus Losartan in Hypertension and Type 2 Diabetes Mellitus Patients With Macroalbuminuria","status":"COMPLETED","sponsor":"InVasc Therapeutics, Inc.","startDate":"2011-06","conditions":"Hypertension, Diabetes Mellitus, Type 2","enrollment":88}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":1,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Cozar"],"phase":"phase_3","status":"active","brandName":"Losartan (Control)","genericName":"Losartan (Control)","companyName":"Boryung Pharmaceutical Co., Ltd","companyId":"boryung-pharmaceutical-co-ltd","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Losartan is a small molecule used to treat conditions such as hypertension, renal insufficiency, obesity, and hyperglycemia. It is an active comparator in clinical trials, including those studying its effectiveness in patients with essential hypertension not adequately controlled with losartan.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}